Fig. 4From: Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational studySurvival analysis by residual disease in overall after primary cytoreductive surgery. a: PFS comparison of residual disease in overall among 0 cm, 0–0.5 cm, 0.5–1 cm, >1 cm; b: PFS comparison of residual disease in overall between <0.5 cm vs. >0.5 cm; c: PFS by residual disease in overall after primary cytoreductive surgery in patients with FIGO stage IIIC. d Progression-free survival by residual disease in overall after primary cytoreductive surgery in patients with FIGO stage IVBack to article page